Tag: Acquisition Advisory
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
A 1,200-article code, five interlocking books, and one tighter leash on Chinese business. The clock to August 2026 is ticking
For Marco Chung, group head of legal at CITIC Securities International, the choice for arbitration seat in China-related disputes is clear